Update on management of herpes keratitis in children

Current Opinion in Ophthalmology

Volumn 24, Issue 4, 2013, Pages 343-347

  Revere, Karen ^a   Davidson, Stefanie L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

acyclovir; diagnosis; herpes keratitis; pediatric; resistance

Indexed keywords

ACICLOVIR; DOUBLE STRANDED DNA; GANCICLOVIR; IDOXURIDINE; NAKED DNA; TRIFLURIDINE; VASCULOTROPIN;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; AMBLYOPIA; ANTIVIRAL THERAPY; ASTHMA; ATOPY; BLINDNESS; CLINICAL EXAMINATION; CORNEA STROMA; CROSS RESISTANCE; CYTOMEGALOVIRUS; DIARRHEA; DRUG SAFETY; EPSTEIN BARR VIRUS; GENE TARGETING; GOLD STANDARD; GRAFT SURVIVAL; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; IMMUNOAFFINITY CHROMATOGRAPHY; IN VITRO STUDY; KERATOCONJUNCTIVITIS; KIDNEY FUNCTION; LACTOSE INTOLERANCE; LENTIVIRINAE; LIVER FUNCTION; MOLECULAR DIAGNOSIS; MOLECULAR WEIGHT; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE RISK; RECURRENT DISEASE; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCAR FORMATION; SYSTEMIC DISEASE; TERTIARY HEALTH CARE; TH1 CELL; TH2 CELL; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VISUAL IMPAIRMENT;

ACYCLOVIR; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOCHROMATOGRAPHY; INFANT; KERATITIS, HERPETIC;

EID: 84880134915     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32836227d8     Document Type: Review

References (23)

1. Smith JS, Robinson NJ. Age specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186:S3-S28.
2. Liu S, Pavan-Langston D, Colby K. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes. Ophthalmology 2012; 119:2003-2008.
3. Chong E, Wilhelmus KR, Matoba AY, et al. Herpes simplex virus keratitis in children. Am J Ophthalmol 2004; 138:474-475.
4. Schwartz GS, Holland EJ. Oral acyclovir for the management of herpes simplex virus keratitis in children. Ophthalmol 2000; 107:278-282.
5. Beigi B, Algawi K, Foley-Nolan A, O'Keefe M. Herpes simplex keratitis in children. Br J Ophthalmol 1994; 78:458-460.
6. Prabriputaloong T, Margolis TP, Lietman TM, et al. Atopic disease and herpes simplex eye disease: a population-based case-control study. Am J Ophthalmol 2006; 142:745-749.
7. Margolis TP, Ostler HB. Treatment of ocular disease in eczema herpeticum. Am J Ophthalmol 1990; 110:274-279.
8. Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003; 112:667-674.
9. Inoue Y, Shimomura Y, Fukuda M, et al. Multicentre clinical study of the herpes simplex virus immunochromatographic assay kit for the diagnosis of herpetic epithelial keratitis. Br J Ophthalmol 2012; 00:1-5.
10. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998; 339:300-306.
11. Manka RL. Exogenous lactase in the treatment of oral acyclovir intolerance. Am J Ophthalmol 1989; 108:733.
12. Zhang W, Suzuki T, Shiraishi A, et al. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation. Cornea 2007; 26:105-106.
13. Yao YF, Inoue Y, Kase T, et al. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates. Graefes Arch Clin Exp Ophthalmol 1996; 234:S126-S132.
14. Mori Y, Inoue Y, Shimomura Y. Herpetic epithelial keratitis caused by acyclovir-resistant strain. Jpn J Ophthalmol 1994; 38:407-410.
15. Gaudreau A, Hill E, Balfour HH, et al. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompro-mised patients. J Infect Dis 1998; 178:297-303.
16. Inoue T, Kawashima R, Suzuki T, Ohashi Y. Real-time polymerase chain reaction for diagnosing acyclovir-resistant herpetic keratitis based on changes in viral DNA copy number before and after treatment. Arch Ophthal-mol 2012; 130:1462-1464.
17. Berdugo M, Larsen IV, Abadie C, et al. Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized antiherpes simplex virus IgG fab fragment following topical application. Antimicrob Agents Chemother 2011; 56:1390-1402.
18. Elbadawy HM, Gailledrat M, Desseaux C, et al. Targeting herpetic keratitis by gene therapy. J Ophthalmol 2012; 56:1390-1402.
19. Stechschulte SU, Joussen AM, Von Recum HA, et al. Rapid ocular angiogenic control via naked DNA deliver to cornea. Inv Ophthalmol Vis Sci 2001; 42:1975-1979.
20. Kim B, Lee S, Suvas S, Rouse BT. Application ofplasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J Immunol 2005; 175:509-516.
21. Pepose JS, Keadle TL, Morrison LA. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 2006; 141:547-557.
22. Koelle DM, Ghiasis H. Prospects for developing an effective vaccine against ocular herpes simplex virus infection. Curr Eye Res 2005; 30:929-942.
23. Hippert C, Ibanes S, Serratrice N, et al. Corneal transduction by intra-stromal injection of AAV vectors in vivo in the mouse and ex vivo in human explants. PLoS ONE 2012; 7:e35318.